Visugromab in Cachexia International Trial
for Cancer-associated Cachexia
Sites in East Brunswick +7 more locations
Sponsor: CatalYm GmbH
Sex: All·Age: 18+
Code: NCT07112196·Phase 2, Phase 3·Recruiting·Listed Aug 2025
Paid Clinical Trials in East Brunswick, NJ
As of August 2026, 58 paid clinical trials are recruiting in East Brunswick, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
57 clinical trials
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
for Advanced or Metastatic Solid Tumor
Sites in East Brunswick +10 more locations
Sponsor: Pliant Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06270706·Phase 1·Recruiting·Listed Feb 2024
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
for Prostate Cancer Castration-resistant Prostate Cancer
Sites in East Brunswick +6 more locations
Sponsor: MBrace Therapeutics
Sex: All·Age: 18+
Code: NCT07145255·Phase 1, Phase 2·Recruiting·Listed Aug 2025
Behavioral Exposure for Introceptive Tolerance RCT
for Exercise Sensitivity
Sites in East Brunswick, New Brunswick & Hillsborough
Sponsor: Rutgers, The State University of New Jersey
Sex: All·Age: 40+
Code: NCT05398276·Recruiting·Listed May 2022
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
for Metastatic Prostate Cancer
Drug: AZD8359
Sites in East Brunswick, Hackensack +2 more locations
Sponsor: AstraZeneca
Sex: Male·Age: 18 - 100
Code: NCT07529717·Phase 1, Phase 2·Recruiting·Listed Apr 2026
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
for Relapsed/Refractory Hematological Malignancies
Sites in East Brunswick +4 more locations
Sponsor: Ascentage Pharma Group Inc.
Sex: All·Age: 18+
Code: NCT07424833·Phase 1·Recruiting·Listed Feb 2026
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
for Gastric Cancer
Drug: Sonesitatug vedotin
Sites in East Brunswick, New Brunswick +70 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
for Adenocarcinoma
Drug: Relacorilant
Sites in East Brunswick, Morristown +12 more locations
Sponsor: Corcept Therapeutics
Sex: All·Age: 18+
Code: NCT07259317·Phase 2·Recruiting·Listed Dec 2025
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
for Neoplasms, Prostate
Sites in East Brunswick +5 more locations
Sponsor: GlaxoSmithKline
Sex: Male·Age: 18+
Code: NCT06990880·Phase 1, Phase 2·Recruiting·Listed May 2025
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
for Endometrial Cancer
Sites in East Brunswick +10 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 130
Code: NCT05489211·Phase 2·Recruiting·Listed Aug 2022
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
for Non-Small Cell Lung Cancer
Drug: Durvalumab
Sites in East Brunswick +22 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT05211895·Phase 3·Recruiting·Listed Jan 2022